Skip to main content
  • Bempedoic Acid: Modest LDL Lowering Affirmed

    CLEAR Wisdom completes the phase III picture; next step, FDA review

    NEW ORLEANS -- The final pivotal trial for bempedoic acid affirmed its modest LDL lowering effect and safety profile.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details